Home About Us Emgen Registration Contact Us Ask Your Scientific Question Answer to your Question Idea and Suggestion Photo Gallery
 
Home
Members
Membership
Director
Steering Committee
News
EMGEN News
Focal Points
Training
MOUs
Reports
Webinar
Facilities and Services
Newsletter
Articles
Journals
Publications
Job Opprtunities
Other Links
Scientists Database
 
  biotech-15
NAMEABOUTRESEARCH GROUP

LithuaniaVilnius 

Institute of Biotechnology
Centre of Excellence

 Institute of Biotechnology, V.A. Graiciuno 8, LT-02241 Vilnius, Lithuania.

Phone: (370 5) 2602103

Fax: (370 5) 2602116

E-mail: office@ibt.lt 

Founded in 1975 as the all Union Research Institute of Applied Enzimology, currently, the Institute of Biotechnology is mainly involved in research and training in the fields of biotechnology and molecular biology, including research and development of recombinant biomedical proteins, genetic and molecular studies of restriction modification phenomenon, developing of viruses diagnostics, epigenetic study of small RNA, drug design and synthesis, bioinformatics. 

1: Laboratory of Biological DNA Modification

Head of Laboratory

Prof. Saulius Klimašauskas, Ph.D., Dr.Habil.phone: 370 5 260214
fax: 370 5 2602116
e-mail:
klimasau@ibt.lt

Main topics:

1:Kinetic and molecular mechanism of DNA methylation

2:Targeted covalent labeling of biopolymers

3:Novel approaches to epigenome profiling

4:Functional analysis of the miRNA methyltransferase HEN1

5: Laboratory of Eukaryote Gene Engineering

Head of laboratory:                      

Prof. Kęstutis Sasnauskas
Dr. Gintautas Žvirblis (since 2008)

Main topics:

1:Hamster polyomavirus-derived virus-like particles

2:Expression of glycoproteins of mump and measles viruses in yeast

3:Technology development of long-acting recombinant proteins

4:Hantavirus vaccine and diagnostic tools

5:Biotechnological approaches to improve plant cold tolerance6:Detection and elimination of viroids and phytoplasmas

3: Laboratory of Immunology and Cell Biology

Head of the Laboratory            

Dr. Aurelija Zvirbliene

Tel. +370 5 2602117    

Fax. +370 5 2602116 

E-mail: azvirb@ibt.lt 

Main topics: 


The Laboratory of Immunology and Cell Biology consists of three research groups. main research topics are: antigenicity studies of recombinant viral proteins and development of monoclonal antibodies (Dr. A.Žvirblienė), regulation of gene expression by alternative splicing (Dr. A.Kanopka), molecular epidemiology of tuberculosis (Dr. P.Stakėnas).

4: Laboratory of Bioinformatics

Head of the Laboratory

Dr. Česlovas Venclovas
Tel.: 8-5-269-1881
Fax.: 8-5-260-2116
E-mail: venclovas@ibt.lt

Main topics: In Bioinformatics Laboratory we mainly deal with protein sequences and their three-dimensional structures. There are two main directions of our research:

Methods development.

We aim at improving computational methods for sequence comparison and protein structure prediction (mainly in comparative modeling) as well as methods for assessment of protein structure quality. 

Application of computational methods to biological problems.

Most often we use computational methods to characterize structure and interactions of both individual proteins and their complexes. In these studies we tend to focus on proteins/protein complexes that function in DNA metabolism including DNA replication,

* recombination and repair. Our objective is to make inferences regarding structural and functional features, molecular mechanisms, interactions, etc. that can be tested experimentally. Most of such studies are joint collaborations with experimentalists. 

5: Laboratory of Biothermodynamics and Drug Design

Head of Laboratory:                    

Dr. Daumantas Matulis

Phone. +370 5 2691884               

Fax. +370 5 2602116                  

Email. matulis@ibt.it  

Main topics: 

The main research interests are in the area of anticancer drug design by structural biothermodynamics. Several protein targets, such as the family of human carbonic anhydrases and the family of human chaperone proteins (especially Hsp90) were chosen as the primary targets of interest by the laboratory. Novel small-molecule compounds are designed in silico, synthesized by chemists, and their inhibition efficiency measured by biophysical techniques.  

 
 
Forgot you password? Forgot Your username? Create an account

 
 
   
 

Home | About Us | Emgen Registration | Contact Us | Downloads | Emgen Forum | You Scientific Question | Photo Gallery
Copyright © 2009 Emhgbn Allright Reserved Design By Ecomiran